BioJeL, the Biological Resource Center of the Jérôme Lejeune Institute
Specialized in intellectual deficiencies of genetic origin
BioJeL, the Biological Resource Center of the Jérôme Lejeune Institute, opened in 2008. This biobank is specialized in the management and distribution of biological resources (DNA, fibroblasts, blood cells, plasma) from patients with intellectual deficiencies of genetic origin. Most of these samples are obtained from patients attending consultations at the Jérôme Lejeune Institute.
BioJeL has 4 collections of samples (DNA, fibroblasts, blood cells, plasma) which are associated with the clinical data of the consultation.
The close links between clinical consultations at the Jérôme Lejeune Institute and BioJeL are a major asset for the implementation of a sampling policy meeting the needs of the scientific community. Clinical consultations take place in the building that houses the biobank, making it possible to treat samples rapidly and to optimize pre-analytical treatment through the use of validated, standardized methods.
In addition to making biological resources available, BioJeL provides a technical platform for:
- Meeting the specific needs of clinical research protocols,
- Collecting samples from patients followed routinely through consultations at the Jérôme Lejeune Institute, whether or not they meet the criteria of the BioJeL sample collection policy.
The use of biological resources of human origin imposes legal and regulatory requirements on each of the parties involved. BioJeL satisfies these requirements for its human sample preparation, storage and diffusion activities. These activities are declared to and authorized by the French Ministry of Higher Education, Research and Innovation:
- Declaration: DC-2009-1043
- Authorization: AC-2015-2579
- Export authorization: IE-2015-814
It should be noted that each of the parties involved must meet the legal and regulatory requirements associated with all activities relating to biological resources of human origin.
Our biobank specializing in intellectual deficiencies of genetic origin provides the scientific community with access to its collections of biological resources. BioJeL, an essential tool for research on intellectual deficiencies of genetic origin, establishes external, national and international collaborations, and supports the Jérôme Lejeune Institute in its clinical research projects, with the aim of advancing knowledge to improve patient management